MDUFA VI: Industry seeks changes to de novo, pre-submission programs
Regulatory NewsJoanne S. Eglovitch
510(k)CBERCDRHHealth Authority meeting and communication strategyMDUFAMedical DevicesPremarket approval (PMA)Regulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)